Biocon is currently trading at Rs. 638.80, up by 5.50 points or 0.87% from its previous closing of Rs. 633.30 on the BSE.
The scrip opened at Rs. 632.00 and has touched a high and low of Rs. 640.50 and Rs. 631.35 respectively. So far 58412 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 718.35 on 26-Sep-2018 and a 52 week low of Rs. 508.00 on 18-Dec-2017.
Last one week high and low of the scrip stood at Rs. 658.45 and Rs. 628.90 respectively. The current market cap of the company is Rs. 38244.00 crore.
The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 21.94% and 17.38% respectively.
US Food and Drug Administration (USFDA) has conducted a GMP inspection at Biocon's API manufacturing facility at Telangana from December 12 to 14, 2018. The inspection concluded without any observations and no Form 483 was issued. The successful inspection of this site reflects company's strong commitment to quality and cGMP compliance.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |